Literature DB >> 10550372

[Immunosuppression caused by head and neck surgery].

F Heimlich1, A Dietz, V Daniel, H Maier.   

Abstract

The immunomodulating effect of primary surgical intervention was investigated in 33 patients with squamous cell carcinomas of the oral cavity, pharynx and larynx. An operation time longer than 7 h was significantly associated with a decrease in lymphocytes, CD4(+) T-lymphocytes and CD8(+) T-lymphocytes. The CD4/CD8-ratio as a marker for the down-regulation of the cellular immune response was slightly decreased but was still in the normal range. CD4-lymphocyte counts increased 7 days after operation while CD8 lymphocytes were found elevated 4 weeks after surgery. The in vitro stimulation of the lymphocytes was impaired for 1 to 4 weeks. Interleukins, interferon-gamma and tumor necrosis factor did not show any changes after surgery. Decreases of lymphocytes, especially CD4(+) and CD8(+) lymphocytes, were significantly associated with the time of operation and the volume of blood loss. Extensive trauma, age, different kinds of anesthesia and intensive care interventions were not associated with specific immunomodulating effects, although these factors might be responsible for suppressing cytokine responses.

Entities:  

Mesh:

Year:  1999        PMID: 10550372     DOI: 10.1007/s001060050529

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  4 in total

1.  Photodynamic therapy with meta-tetrahydroxyphenylchlorin (Foscan) in the management of squamous cell carcinoma of the head and neck: experience with 35 patients.

Authors:  Kai Johannes Lorenz; Heinz Maier
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-03-17       Impact factor: 2.503

2.  [Long-term changes in peripheral blood leukocyte and lymphocyte populations in ENT-carcinoma patients. A flow cytometric study in 346 ENT-carcinoma patients and 31 healthy controls].

Authors:  J Ostwald; S Dommerich; U Schulz; B Kramp
Journal:  HNO       Date:  2004-08       Impact factor: 1.284

3.  [Bacterial osteitis. Special considerations in immunocompromised patients].

Authors:  C Niedhart; O Miltner; K-W Zilkens; F U Niethard
Journal:  Orthopade       Date:  2004-03       Impact factor: 1.087

4.  [Squamous cell carcinoma of the head and neck. Photodynamic therapy with Foscan].

Authors:  K J Lorenz; H Maier
Journal:  HNO       Date:  2008-04       Impact factor: 1.284

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.